Alkem Laboratories Q3 Results
- BSE: 539523
- NSE: ALKEM
- ISIN: INE540L01014
- Sector: Biotechnology & Drugs
BSE
5,399.00
-19.75 (-0.36%)
-19.75 (-0.36%)Volume17.23 K
Updated: Fri 14 Aug, 2026 | 15:29:35
NSE
5,368.00-81.50 (-1.50%)
-81.50 (-1.50%)Volume6.36 L
Updated: Fri 14 Aug, 2026 | 15:50:30
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q3 Results Highlights
Quarter ended Dec 25
Note: Comparison is on QoQ basis
Quarterly - Alkem Laboratories Q3 Results
*All figures in crores except per share values
| Fiscal Period | Dec 25 | Sep 24 | QoQ Comp | Dec 23 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 3,056.62 | 2,740.75 | -3.69% | 2,685.84 | 13.20% |
| Depreciation/ Amortization | 95.01 | 78.91 | 1.50% | 69.56 | 11.41% |
| Operating Income | 680.20 | 673.92 | -17.77% | 638.03 | 0.90% |
| Net Income | 636.02 | 688.64 | -16.87% | 594.96 | 1.63% |
| Other Operating Expenses Total | 914.60 | 846.65 | -5.61% | 739.59 | 16.40% |
| Net Income Before Taxes | 780.70 | 780.26 | -12.80% | 654.90 | 6.79% |
| Total Revenue | 3,736.82 | 3,414.67 | -6.60% | 3,323.87 | 10.74% |
| Selling/ General/ Admin Expenses Total | 721.51 | 610.49 | 1.59% | 572.15 | 15.48% |
| Diluted Normalized EPS | 56.88 | 57.60 | -11.11% | 49.76 | 8.68% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.